Further, although TGF-β has been implicated to promote cancer cachexia[30, 31], to our knowledge, TGF-β blockade has not been studied as a therapeutic strategy in the treatment of pancreatic cancer cachexia. The gene discussed is TGFB1; the disease is cancer.